The present invention relates to a cushion for a respiratory mask assembly used for providing ventilatory support, e.g., for treatment of Sleep Disordered Breathing (SDB) with Non-invasive Positive Pressure Ventilation (NPPV).
The use of NPPV for treatment of SDB such as Obstructive Sleep Apnea (OSA) was pioneered by Sullivan (see U.S. Pat. No. 4,944,310). Apparatus for the treatment of SDB involves a blower which delivers a supply of air at positive pressure to a patient interface via a conduit. The patient interface may take several forms, such as a nasal mask assembly and a nasal and mouth mask assembly. Patients typically wear a mask assembly while sleeping to receive the NPPV therapy.
Mask assemblies typically comprise a rigid shell or frame and a soft face-contacting cushion. The cushion spaces the frame away from the patient's face. The frame and cushion define a cavity which receives the nose or nose and mouth. The frame and cushion are held in position on the patient's face by a headgear assembly. The headgear assembly typically comprises an arrangement of straps which pass along both sides of the patient's face to the back or crown of the patient's head.
U.S. Pat. No. 5,243,971 (Sullivan and Bruderer) describes a nasal mask assembly for Continuous Positive Airway Pressure (CPAP) having a ballooning/molding seal that conforms with the patient's nose and facial contours. The mask assembly has a face-contacting portion mounted to a shell which is sized and shaped to overfit the nose region of the patient. The face-contacting portion is in the form of a distendable membrane which is molded from an elastic plastics material. The distendable membrane and the shell together define a chamber. Pressurized gas admitted to the chamber causes the membrane to distend outwardly from the patient's face. The contents of this patent are hereby incorporated by reference.
U.S. Pat. No. 6,112,746 (Kwok et al.) describes a nasal mask assembly and a mask cushion therefor. The cushion comprises a substantially triangularly shaped frame from which extends a membrane. The frame has a scalloped edge by which the cushion is affixed to a mask body. The membrane has an aperture into which the patient's nose is received. The membrane is spaced away from the rim of the frame, and its outer surface is of substantially the same shape as the rim. The contents of this patent are hereby incorporated by reference.
In a traditional mask assembly including a cushion, a seal is formed between the cushion and the face of a patient as the result of a contact force which acts along a contact line of the cushion. The contact force typically is a function of tension in the headgear straps which acts through the frame of the mask assembly, the walls of the cushion and the seal-forming portion of the cushion. In a traditional mask assembly, the frame defines a cavity or volute adapted to receive at least a portion of the nose, with the cushion forming a perimeter of the cavity. Thus, in use, the portion of the patient's face within the cavity is exposed to air or breathable gas at positive pressure and hence receives a force as the result of that positive pressure.
PCT Patent Application AU01/00746, published as WO 01/97893 (Frater et al.), describes a mask assembly for delivering air to a patient that includes a suspension mechanism to allow relative movement between a face-contacting cushion and a mask shell. The suspension mechanism also provides a predetermined force to the cushion that is a function of mask pressure, displacement of the cushion, or both. The contents of this patent are hereby incorporated by reference.
U.S. Pat. No. 5,074,297 (Venegas) describes a respiratory mask assembly for use with intermittent positive pressure breathing treatment which is said to facilitate the formation and automatic adjustment of the seal between a patient's face and a facial unit of the respiratory mask. The respirator mask assembly comprises a facial unit, an expandable piston adjacent the facial unit and a rigid support structure attached to one end of the piston, and an attachment mechanism for securing the mask assembly to a patient. During the inspiration portion of the ventilation cycle a positive pressure is developed within the mask assembly, causing the piston to expand. Because the attachment mechanism and the support cooperate to resist significant expansion of the piston, a force is generated which presses the facial unit against the patient's face and maintains an air tight seal. When pressure within the mask unit decreases, the contact force on the facial unit is likewise decreased and the seal is eliminated.
A common problem with prior art mask assemblies, such as the mask assemblies taught by U.S. Pat. Nos. 5,074,297, 5,243,971 and 6,112,746 and PCT Patent Application AU01/00746, is patient comfort. Patients can develop sores and red marks on their faces after several hours use of a mask assembly. The nasal bridge area of the patient's face has been identified as being particularly sensitive.
Moreover, the face contacting portion may apply excessive pressure to the wearer's face resulting in discomfort and possibly skin irritation. This can occur when the face contacting portion is distorted beyond its normal range of elasticity to conform to certain facial contours, thus requiring the application of excessive forces to obtain a seal. In some cases, these excessive pressures and forces may cause the wearer's face to distort to conform with the face contacting portion, which increases wearer discomfort, facial soreness and ulceration.
Another common problem with prior art mask assemblies is buildup of CO2 in the mask cavity. Mask assemblies typically include a vent which allows the continuous washout of exhaled gasses from the cavity. One factor affecting the washout of exhaled gases is the dead space within the mask cavity.
Another common problem with these masks is a broken or ineffective seal, for example, the mask may become dislodged if the wearer rolls over when sleeping, thereby creating a drag force on the gas supply line which is transmitted to the mask and breaking the seal between the mask and wearer. If a mask is used for the administration of Continuous Positive Airway Pressure (CPAP) treatment for the condition obstructive sleep apnea, such a leak can result in a pressure supplied to the entrance of the wearer's airway that is below the therapeutic value. Thus, treatment becomes ineffective.
Another problem with mask assemblies which include a gusset section is visual size, both perceived and actual.
Another problem with existing full face masks occurs when wearers move their jaws during treatment, which often happens. As a result, air leaks are created below the mouth from the mid-region extending to the region at the sides or corners of the mouth.
It would be desirable to design a respiratory mask that can be securely sealed to a wearer's face without causing discomfort and minimize leak.
One aspect of the invention is directed towards a mask assembly having a cushion that provides more comfort to the patient.
Another aspect of the invention is directed towards a mask assembly having a cushion that controllably distributes facial contact pressure around the patient's face.
Another aspect of the invention is directed towards a mask assembly having a cushion that controllably distributes facial contact forces around a contact line on the patient's face.
Another aspect of the present invention provides a respiratory mask assembly for delivering breathable gas to a patient. The respiratory mask assembly according to one embodiment includes a frame and a cushion. The cushion has a non-face contacting portion structured to be connected to the frame, a face-contacting portion structured to engage the patient's face, and an intermediate portion that interconnects the non-face contacting portion and the face-contacting portion. The intermediate portion includes a gusset portion that applies a first component of force to the patient's face through the face-contacting portion. A spring structure is coupled with the face-contacting portion of the cushion. The spring structure applies a second component of force to the patient's face through the face-contacting portion. The first and second components of force applied by the gusset portion and spring structure, respectively, determine a contact force of the cushion applied to the patient's face through the face-contacting portion.
Another aspect of the invention is directed towards a mask assembly having a curvature which follows the line of the patient's face.
Another aspect of the invention is directed towards a mask assembly having a gusset portion which has minimal impingement of a patient's vision.
Another aspect of the invention is directed towards a mask assembly having a cushion with a gusset portion which has a low profile.
Another aspect of the invention is directed towards a mask assembly having a gusset portion which seals at a low pressure and which is comfortable at high pressures.
Another aspect of the invention is directed towards a mask assembly having a cushion with gusset portion which provides stop structures to regulate pressure distribution.
Another aspect of the invention is directed towards a mask assembly having a gusset portion providing additional footprint area and a spring section with a spring constant constructed so that the forces on the face from the cushion are a function of the additional footprint area, the mask pressure and the spring constant of the spring section.
Another aspect of the invention is to provide an elastic cuff to the cushion. The elastic cuff may have a modulus of elasticity which is greater than a modulus of elasticity of the remaining portions of the cushion, such that it may vary more easily deform or stretch in response to localized pressure and/or force changes between the mask and the wearer's face, thereby avoiding a compromise in the seal during movement of the patient. The elastic cuff may be formed in one piece with the cushion, along an intermediate portion of the cushion between the contacting and non-contacting portions of the cushion. The elastic cuff may also be formed separate from the cushion and assembled to the contacting and/or non-contacting portions of the cushion.
A further aspect of embodiments of the invention provides a full face mask with a cushion that forms a stable and reliable seal with a wearer's face.
An additional aspect of embodiments of the invention provides a full face mask that effectively seals the region directly below and/or to the sides of the lower lip.
A further aspect of embodiments of the invention provides a full face mask that offers effective sealing at relatively high pressures.
Another aspect of embodiments of the invention provides a full face mask that abuts the more stable bony regions of a wearer's face.
A further aspect of embodiments of the invention provides a full face mask that follows the natural contour of the face's bony structure below the mouth.
In one example, a full face respiratory mask comprises a frame including a breathable gas port and cushion. The frame defines an inner chamber that receives a wearer's nasal region and mouth. The cushion includes a flange connected to the frame, an inner rim defining an opening to the inner chamber of the frame, and a sealing portion disposed between the flange and the inner rim that contacts the wearer's face. The sealing portion includes a nasal seal section that spans a wearer's face above the wearer's nares, side seal sections extending from each side of the nasal seal section on both sides of the wearer's mouth, and a chin seal section that extends between the side sections. The chin seal section is upwardly curved in an arch to follow the chin's bony contour.
In another example, a cushion for use in a full face respiratory mask, comprises a flange for connection to a mask frame, an inner rim defining an opening for surrounding the wearer's nares and mouth, and a sealing portion disposed between the flange and the inner rim that contacts the wearer's face. The sealing portion includes a nasal seal section that spans a wearer's face above the wearer's nares, side seal sections extending from each side of the nasal seal section on both sides of the wearer's mouth, and a chin seal section that extends between the side sections, wherein the chin seal section is upwardly curved in an arch to follow the chin's bony contour.
Principles of these examples may be applied to any type of cushion for use on a respiratory mask, including but not limited to silicone elastomer, gel, foam or any combination thereof.
Principles of these examples may be applied to any type of respiratory mask, including CPAP systems or non-positive ventilation masks, such as respirators.
Other aspects, features and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.
The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:
In the illustrated embodiment, the mask assembly 10 is a nasal mask structured to deliver breathable gas to a patient's nose. However, the mask assembly 10 may be nasal and mouth mask or the mask assembly may be a full-face mask.
A swivel elbow assembly 22 is removably attached to a front portion of the frame 12. The elbow assembly 22 is structured to be connected to a conduit that is connected to a pressurized supply. The pressurized supply supplies pressurized breathable gas through the conduit and elbow assembly 22 and into the cushion 14 for breathing by the patient.
As shown in
In the illustrated embodiment, the non-face-contacting portion 24 of the cushion 14 is removably attached to the frame 12. For example, as shown in
As shown in
The membrane 40 provides a large effective rolled over section (large radius) to allow some degree of movement or rotation of the mask assembly 10 relative to the patient's face, and prevents the membrane distal edge from irritating the patient's face. Further, the membrane 40 extends further than the edge of the rim 38 to prevent the rim 38 from being a source of irritation.
The rim 38 has a curved shape that curves inwardly into the nasal cavity of the cushion 14. While it is preferable that the membrane 40 be thinner than the rim 38, they could have the same thicknesses.
The inside surface of the membrane 40 is spaced from the outside surface of the rim 38 so as to form a compliant seal with the patient. By compliant seal, it is meant that the membrane 40 can accommodate small variations in the shape of a patient's facial/nasal features without undue force, and can account for small movement of the mask relative to the patient during use, while maintaining an effective seal. The spacing between the rim 38 and membrane 40 may vary in different regions of the patient's face.
As shown in
The cushion 14, including the gusset portion 50, is curved to generally follow the curvature of the face. See
In the illustrated embodiment, the membrane 40 is structured to contact an upper portion of the nasal bridge region of the patient. However, the membrane 40 may contact a lower portion of the nasal bridge region. For example, see U.S. Provisional Application No. 60/402,509, filed on Aug. 12, 2002, the contents of which are hereby incorporated by reference.
In the illustrated embodiment, the face-contacting portion 26 of the cushion 14 has a double-walled construction, e.g., one membrane 40 and one rim 38. However, the cushion 14 may have a single walled, triple walled or more walled construction. For example, a cushion with a combined membrane and rim could be provided, e.g., a single walled construction. Conversely, the support function of the rim could be accomplished with two or more support rims to support a single membrane, or two or more membranes could be provided over a single rim. In another alternative, the support function of the rim and the sealing function of the membrane could be split into two different members, which may be made of different materials, for example either being made of a foam. In another embodiment, a gel membrane may be used.
The intermediate portion 28 of the cushion 14 includes a gusset portion 50 that extends radially outwardly with respect to the non-face-contacting and face-contacting portions 24, 26. The gusset portion 50 allows the face-contacting portion 26 to move relative thereto. Furthermore, the gusset portion 50 has a larger footprint area than the face-contacting portion 26 (e.g.,
As shown in
The gusset portion 50 has an inner edge 58 and an outer edge 60. The inner edge 58 corresponds to an outer edge of the side wall 36 and the outer edge 60 corresponds to an apex of the arcuate wall 56 of the gusset portion 50. A perpendicular distance d is defined between the inner and outer edges 58, 60, as shown in
An aspect of the invention is that the contact force is controllably distributed around the patient's face. The pressures and forces should be distributed while maintaining the cushion's seal. It is desirable to avoid localized pressure points along sensitive regions of the patient's face. For example, localized points of contact force should be avoided in the nasal bridge region to increase comfort to the patient.
Another aspect of the invention is that not only can the contact force be redistributed while maintaining the cushion seal, but also the patient's field of view can be optimized by reshaping the gusset area around the eyes. For example, as shown in
Since the contact force applied to the patient's face is proportional to the footprint area of the gusset portion 50, it is possible to vary the force applied to different regions of the patient's face by varying the distance d in different regions of the gusset portion 50. For example,
The gusset portion 50 can be provided in only selected regions of the face, and not others. It need not be provided along the entire perimeter of the cushion. For example, the gusset portion 50 could be provided along only the lip portion.
Thus, the gusset portion 50 with the outer edge 260 in dashed lines has a smaller contact force applied to the nasal bridge and lip regions of the patient's face than the gusset portion 50 with the outer edge 60 in a solid line. In this way, the contact force applied to the patient's face can be redistributed away from more sensitive areas of the patient's face, e.g., nasal bridge and lip region, and applied to less sensitive areas of the patient's face, e.g., cheek regions. Since the nasal bridge region of the patient's face is particularly sensitive, a gusset portion 50 with a reduced area in the nasal bridge region 42 should be more comfortable for the patient. However, the distance d can be tailored for any region of the gusset portion 50 to tailor the force applied to any region of the patient's face for maximum comfort. This can be done on a customized basis to get both an ideal force and a customized area around the cushion.
The contact force applied to the contact line on the patient's face can be further tailored by adjusting a thickness of the arcuate wall 56 of the gusset portion, as shown in
Alternatively, the whole gusset portion 50 may be tapered, not just the arcuate wall.
The contact force applied to the contact line on the patient's face can be further tailored by providing internal stop structures 59 as shown in
In another form, the contact force applied to the contact line on the patient's face can be tailored by inserting a spring (e.g. a steel spring) in the gusset portion 50. The spring has a spring constant that is designed to allow adjustment of the component of force applied by the spring.
In these ways, the contact force on the contact line of the face is not solely a function of mask pressure, but can also, for example, be a function of the spring element within the gusset portion 50. This improves low pressure stability, reduces the sealing force at high pressure, and reduces the visual impact a large gusset portion might otherwise have.
In the illustrated embodiment, the gusset portion 50 as well as the non-face-contacting and face-contacting portions 24, 26 of the cushion 14 have a generally triangular shape. However, the gusset portion 50 and non-face-contacting and face-contacting portions 24, 26 of the cushion 14 may have any suitable shape, e.g., non-triangular shape. Further, the shape of the gusset portion 50 and non-face-contacting and face-contacting portions 24, 26 may be similar to one another or may be different from one another, e.g., the gusset portion has a triangular shape and the face-contacting and non-face-contacting portions have a generally trapezoidal shape.
The cushion 14 is constructed from a soft, flexible skin-compatible material such as silicone. The cushion 14 may be formed, for example, in a one shot injection molding process as is known in the art. However, the cushion 14 may be formed with any suitable material and may be formed by any suitable process. For example, while face contacting portion 26 of cushion 14 may have a softer grade material, the gusset portion may have a harder grade material to provide stiffness as a spring element. The non-face contacting portion 24 may have a stiffer grade material so a direct assembly to frame without a cushion clip may be possible.
The cushion 14 provides improved seal stability and comfort over prior art cushions. Specifically, the curvature of the cushion 14 improves stability of the mask assembly generally and the gusset portion improves stability of seal. Changing the distances d and d2 of the gusset portion in different regions of the patient's face improves patient comfort level.
The face-contacting portion 26 of the cushion 14 has a surface which may be described by a function of at least one parameter, p, varying from 0 to 360 degrees representing angular position. With respect to the nose, the 0 degree position may be defined to be mid-nasal bridge and the nasal septum will occur at 180 degrees.
An advantage of the mask assembly 10 is that the contact force acting through the contact strip can be tailored to provide an acceptable seal at low mask pressures while not being too high at high mask pressures. For example, in a mask assembly having a gusset portion with no spring structure, the contact force might be too low at low mask pressures to provide a seal, forcing designers to increase the gusset area. This additional gusset area in turn would lead to an excessively high contact force at high mask pressures. The combination of a spring structure with a gusset portion means that at low mask pressures, the contact force may be provided by the spring structure, with the gusset portion making little additional contribution. At high mask pressures, the contact force provided by the gusset portion may be much greater than that provided by the spring structure. Thus, the mask assembly 10 provides a means to tailor the contact forces of a mask system over a range of pressures.
In another form of the invention, the extensibility of the headgear is changeable. For example, relatively inextensible headgear might be used for low mask pressures, while more extensible headgear may be used for high mask pressures, such as around 20 cm H2O. In one form, this is achieved by having duplicate straps within the headgear, one extensible, the other, relatively inextensible. At low pressures, both straps are used, the net effect being that the headgear is relatively inextensible. At high pressures, the inextensible strap is disengaged, with the result that the headgear is relatively extensible overall.
In accordance with an embodiment of the invention, the cushion is designed to include a gusset portion and spring structure such that the contact force applied by the cushion is maintained within the zone of comfort and seal Z.
A first line L1 represents a cushion with a gusset portion which has an additional footprint area of A1 and which does not include a spring structure. As illustrated, the contact force is below the minimum contact force required to make a seal for mask pressures below about 7 cm H2O. Thus, the cushion represented by line L1 falls outside the zone of comfort and seal Z. For higher pressures (e.g., mask pressures above about 7 cm H2O), the contact force from the gusset portion is sufficient to maintain a seal.
A second line L2 represents a cushion according to one embodiment of the invention with a gusset portion which has an additional footprint area of A1 and includes a spring structure. The effect of the spring structure is to provide an additional contact force at low mask pressures when the effect of the gusset portion is insufficient to provide the minimum sealing force. As a result, the cushion maintains a seal through the range of operating pressures. Moreover, the cushion represented by line L2 falls within the zone of comfort and seal Z throughout the range of operating pressures.
A third line L3 represents a cushion with a gusset portion which has an additional footprint area of 2×A1 and does not include a spring structure. The extra footprint area (twice that of the cushions represented by L1 and L2) results in the contact force of the cushion being sufficient to maintain a seal at a low mask pressure of 4 cm H2O. However, for mask pressures above about 10 cm H2O, the contact force exceeds the maximum comfortable contact force. Thus, the cushion represented by line L3 falls outside the zone of comfort and seal Z.
Thus, by combining a gusset portion with a spring structure in a cushion, a designer can tailor the contact force of the cushion such that it falls within the zone of comfort and seal Z throughout the working range of pressure. The same principles may be applied for different pressure ranges.
Further, the size of the zone Z may change (e.g., by changing the maximum comfortable contact force) depending on a particular region of the patient's face. For example, the maximum comfortable contact force may be reduced for a nasal bridge region of the face. As a result, the cushion can be tailored for that particular region such that it falls within the zone of comfort and seal Z throughout the range of operating pressures.
As illustrated, the addition of a spring structure to a cushion having a gusset portion increases Fmask generally throughout the range of gusset extensions. As a result, a cushion may be constructed with a gusset portion having a smaller footprint area than would otherwise be required to provide sufficient Fmask to maintain a seal.
Further, the effect of the spring on Fmask can be determined for various mask pressures so that the cushion can be tailored for particular regions of the patient's face.
Elastic Cuff
The frame includes an inlet 122 which is in communication with the source of pressurized air or breathable gas. Preferably, the inlet is connected to a swivel elbow which in turn is connected to an air delivery tube.
The cushion 114 includes a non-contacting portion 124 which is provided to the mask frame 112, as described above. The cushion 114 further includes a face contacting portion 126 and an intermediate portion 128 which is between the non-contacting portion and the face contacting portion 126. The face contacting portion 126 includes a face-contacting seal portion 168 including a membrane 140 and a rim 138, as described above.
The intermediate portion 128 may be provided with at least one cuff 170 that may be resiliently inflatable. The cuff 170 includes walls that can stretch as opposed to being simply flexible. As the straps 116 are tightened, membrane 140 and rim 138 are pushed onto the face. This action causes a force to be applied to the membrane 140, the rim 138 and the face-contacting portion 126, displacing the face contacting portion 126 in the direction of the non-contacting portion 124. The displacement of the face contacting portion 126 and its associated force causes the cuff 170 to balloon outwards. The force is dependent on the degree of strap tightening and the stiffness (force-displacement relationship) of the cuff 170. Initial inflation of the cuff 170 can be achieved via a valve 175. The valve 175 can be in communication with the same source which provides pressurized air to the breathing chamber 171 of the mask assembly 100, or the source can be a separate pressurized source independent of the source for providing pressurized breathable gas to the breathing chamber 171. The elastic cuff 170 can be formed in a single piece with the cushion 114. Alternatively, the elastic cuff 170 may be formed separately from the cushion 114, and later attached, e.g., using adhesives, mechanical fasteners, or the like, etc.
Current mask systems use inflatable cuffs that are relatively stiff being made from materials having a relatively high modulus of elasticity. By contrast the cuffs 170 of the present embodiment are designed to have a relatively low stiffness. This is achieved, e.g., by providing the cuffs 170 with walls that stretch under relatively low forces. Walls with this characteristic typically are made from a material with a relatively low modulus of elasticity. For example, the modulus of elasticity of the material of the elastic cuff material, as determined by bench testing, is in the range of 0.15 MPa to 0.6 MPa. The preferred value for the modulus of elasticity is in the range of 0.25 MPa to 0.45 MPa. In one example, the modulus of elasticity is about 0.35 MPa. In comparison, the gusset portion described above may have a modulus of elasticity of 0.40 MPa to 0.80 MPa, and preferably the modulus of elasticity is about 0.60 MPa. The modulus of elasticity for both the gusset and the elastic cuff 170 can be more or less than that stated above or modified to give the appropriate stretch characteristics in conjunction with the delivered mask pressure and headgear tension/strap displacement.
In the embodiments described above, for example in relation to
Prior art masks use inflatable (verses elastic) cuffs or pneumatic seals and/or seal rings. These inflatable cuffs are typically made from PVC that has a relatively high modulus of elasticity causing them to be relatively stiff. Bench testing of this PVC material found that the modulus of elasticity was of the order of 5.2 MPa. Although they may include some flexibility, it is not resiliently expandable like the elastic cuff 170 shown in
In contrast, the graph of
Therefore, one aspect of this embodiment is to produce an elastic cuff from a material with a relatively low modulus of elasticity, like that of a stretchy balloon. The elastic cuff material has the ability to stretch under standard strap tension experienced in this application.
When the mask is not fitted, the inflatable cuff is not necessarily under pressure. When fitted correctly, the cuff is compressed as the straps are tightened. Given the low modulus of elasticity of the elastic cuff material, the cuff is designed to stretch, billow, bloat and/or swell as the cuff elongates as shown in phantom in
The force applied to the cushion seal could be fine tuned by modifying the stiffness of the cuff walls, e.g., increasing or decreasing the modulus of elasticity, or by pre-pressurizing the elastic cuff 170 via a valve that, in this example, would increase cushion seal forces when the cushion is displaced and/or fitted into position and the straps tensioned.
As shown in
A stiffer cuff made from a material with a higher modulus of elasticity would produce a greater rate of fall as compared to that shown in
In a further embodiment, the elastic cuff 170 may be filled with any compressible or non-compressible fluid, or some combination thereof. The fluid could be, for example, air, flowable liquid, flowable or semi-flowable gel. In the case of air, the cuff walls in tension cause the air inside the cuff to compress and forces the cushion seal outwards towards the face; there is some compression of the air as it is a gas. In the case of liquid filled, all the force onto the cushion seal is acted on by the cuff wall tension alone without the influence of compressed gas also.
Change in behavior of the cushion is achieved by any of or combination of modulus of elasticity, geometry/shape of the elastic cuff, material choice (for example the modulus of elasticity), and the initial mass of fluid (before fitting).
The initial mass of fluid may be adjusted by a valve either manually or automatically (incorporating external-internal control relative to cuff pressure and/or treatment CPAP pressure). In
In
In another embodiment, the elastic cuff may be pressurized with a manual pump 180 to fine tune the initial mass of fluid in the elastic cuff 170. See, for example,
Another embodiment may incorporate automatic cuff mass of fluid change that can synchronize to delivered treatment pressure and/or react to leak or discomfort sensing.
Any elastic material that can be formed into a chamber or the elastic cuff 170 may be used. The use of a latex balloon is one material that may be used. Also, low durometer and/or low modulus of elasticity characteristic silicone rubbers may also be used, or a combination thereof. The cuff may have rigid or semi-rigid detail to provide structural integrity.
The cuff 170 need not surround the entire perimeter. For example, it may be excluded around the nasal bridge to modify received cushion seal forces. The elastic cuff 170 as disclosed herein may also be incorporated or used in conjunction with prior art mask systems, to create a new and improved product. For example, Respironics makes a “Profile Lite” gel cushion that could incorporate the elastic cuff 170 either integrated or otherwise attached between the frame and sealing interface. The elastic cuff may be filled with a compressible or non-compressible fluid such as air or gel, or any combination thereof.
In another example, the elastic cuff 170 may be combined with aspects of U.S. Pat. No. 4,971,051 to Toffolon. The elastic cuff could be incorporated as part of the cushion assembly to provide a force action in the cushion seal and also independent movement/displacement of the cushion seal relative to the mask frame.
While a nasal mask has been described in the preferred embodiments, the principles of the invention can be applied to full-face masks or mouth masks. Furthermore, the principles of the invention can be applied to nasal masks having a very small sealing region sealing near the nares.
“Boomerang” Seal
The frame 12 is preferably saddle shaped, generally triangular or trapezoidal to fit over the wearer's nose, or at least over the wearer's nares, and extends downwardly on each side of the mouth to the chin. The frame 12 has a port 18 for connection to a breathable gas supply 20 through a swivel elbow assembly 22. The gas supply 20 may be a pressurized gas supply that supplies breathable gas to an inner chamber in the mask 10 that receives the wearer's nose and mouth.
The frame 12 also preferably includes a vent opening 24 through which expired gas is exhausted. Fasteners 26 are provided to secure the straps 16 of the head gear and allow selective adjustment of the head gear. In this case, the fasteners 26 are slots formed in the frame 12 through which the straps 16 are fed. Of course, any suitable fastener can be used. If desired, a forehead support may also be used, which would extend from the frame upward toward the forehead.
The frame 12 is shown alone with the cushion 14 in
In
Preferably, the cushion 14 is formed of a soft, flexible skin compatible material such as silicone. One suitable material is SILASTIC™, a silicone elastomer manufactured by Dow Corning. It may be molded, by a one shot injection process as known in the art, for example. Different portions of the cushion 14 may be made with different thicknesses, or even of different materials to affect stiffness and resiliency for example. It is also contemplated that the cushion 14 may be made in whole or in part of foam or gel materials. The cushion 14 may be made based on a combination of the above processes and materials.
The inner rim 32 and sealing portion 36 are best seen in
The embodiment shown herein has a single rim 32 and a single sealing portion 36 thus forming a double walled construction. It is also possible to have a single, triple or multiple walled construction. Further, the rim 32 and the sealing portion 36 could be made of different materials.
If desired, the sealing portion 36 can include a gusset portion that is a gently curved enlarged portion that follows the curvature of the face.
The sealing portion 36 is designed to contact the wearer's face and form a seal therewith so that the gas supplied to the inner chamber of the frame 12 does not leak outside the mask 10. The sealing portion 36 includes a nasal section 38 that spans the nasal area, which extends above the wearer's nares across the bridge of the nose and is generally an inverted V-shape as seen in
The profile of the cushion 14 when viewed from above or below has an concave central portion at the nasal end and the chin end and a convex portion at the cheek portions to fit a wearer's face as seen in
Referring to
This shape allows the side sections 40 to extend farther downward toward the lower jaw. If desired, the cushion 14 can be sized to extend to the lower jaw to provide more stable support. By this, the cushion 14 rests on the bony regions of the face that are less likely to change shape and compromise the seal than the softer, fatty regions like the lower lip and cheek.
During treatment, as pressure is applied to the wearer, the lips, which are flexible, are forced slightly open. The lower lip thus moves outwardly and slightly downwards. As the lower lip moves as described, an intimate contact with the arch shaped cushion 14 is created, improving the sealing even further, and/or reducing leak through the mouth, if desired.
The cushion 14 and mask 10 have been described with reference to CPAP or assisted respiration treatment, however it is to be understood that the invention generally is applicable to any application where gas and/or atomized liquid is to be supplied to the entrance of the airways. Such applications include nebulisers, gas masks and anesthetic machines. In addition, the mask can be for use with an oral only mouth mask where the mask covers the mouth only. Also, the cushion could extend down beyond the chin to further stabilize the cushion.
It can thus be appreciated that the aspects of the present invention have been fully and effectively accomplished. The foregoing specific embodiments have been provided to illustrate the structural and functional principles of the present invention, and are not intended to be limiting. To the contrary, the present invention is intended to encompass all modifications, alterations and substitutions within the spirit and scope of the detailed description.
This application is a continuation of U.S. patent application Ser. No. 14/251,000, filed Apr. 11, 2014, now allowed, which is a continuation of U.S. patent application Ser. No. 13/067,211, filed May 17, 2011, now U.S. Pat. No. 8,733,358, which is a continuation of U.S. patent application Ser. No. 12/382,517, filed Mar. 18, 2009, now U.S. Pat. No. 7,958,893, which is a divisional of U.S. patent application Ser. No. 10/655,622, filed Sep. 5, 2003, now U.S. Pat. No. 7,523,754, which claims the benefit of U.S. Provisional Application No. 60/424,686, filed Nov. 8, 2002, U.S. Provisional Application No. 60/483,622, filed Jul. 1, 2003, and is a Continuation-In-Part of U.S. Non-Provisional application Ser. No. 10/235,846, filed Sep. 6, 2002, now U.S. Pat. No. 6,823,869, which in turn claims priority to U.S. Provisional Application No. 60/317,486, filed Sep. 7, 2001 and U.S. Provisional Application No. 60/342,854, filed Dec. 28, 2001. Each of the above identified applications is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
443191 | Illing | Dec 1890 | A |
781516 | Guthrie, Jr. | Jan 1905 | A |
1081745 | Johnston | Dec 1913 | A |
1125542 | Humphries | Jan 1915 | A |
1192186 | Greene | Jul 1916 | A |
1229050 | Donald | Jun 1917 | A |
1282527 | Bidonde | Oct 1918 | A |
1362766 | McGargill | Dec 1920 | A |
1445010 | Feinberg | Feb 1923 | A |
1610793 | Kaufman | Dec 1926 | A |
1873160 | Sturtevant | Aug 1932 | A |
2353643 | Bulbulian | Jul 1944 | A |
2415846 | Randall | Feb 1947 | A |
2433565 | Korman | Dec 1947 | A |
2625155 | Engelder | Jan 1953 | A |
2706983 | Matheson | Apr 1955 | A |
2931356 | Schwarz | Apr 1960 | A |
3013556 | Galleher | Dec 1961 | A |
3330273 | Bennett | Jul 1967 | A |
3670726 | Mahon et al. | Mar 1972 | A |
3682171 | Dali et al. | Aug 1972 | A |
3739774 | Gregory | Jun 1973 | A |
3754552 | King | Aug 1973 | A |
3861385 | Carden | Jan 1975 | A |
3902486 | Guichard | Sep 1975 | A |
3905361 | Hewson et al. | Sep 1975 | A |
3938614 | Ahs | Feb 1976 | A |
3972321 | Proctor | Aug 1976 | A |
4006744 | Steer | Feb 1977 | A |
4142527 | Garcia | Mar 1979 | A |
4153051 | Shippert | May 1979 | A |
4156426 | Gold | May 1979 | A |
4248218 | Fischer | Feb 1981 | A |
4263908 | Mizerak | Apr 1981 | A |
4264743 | Maruyama et al. | Apr 1981 | A |
4267845 | Robertson, Jr. et al. | May 1981 | A |
4273124 | Zimmerman | Jun 1981 | A |
4312359 | Olson | Jan 1982 | A |
4367735 | Dali | Jan 1983 | A |
4367816 | Wilkes | Jan 1983 | A |
4406283 | Bir | Sep 1983 | A |
4414973 | Matheson et al. | Nov 1983 | A |
4422456 | Teip | Dec 1983 | A |
4449526 | Elam | May 1984 | A |
4455675 | Bose et al. | Jun 1984 | A |
4493614 | Chu et al. | Jan 1985 | A |
4548200 | Wapner | Oct 1985 | A |
4549542 | Chein | Nov 1985 | A |
4572323 | Randall | Feb 1986 | A |
4587967 | Chu et al. | May 1986 | A |
4601465 | Roy | Jul 1986 | A |
4617637 | Chu et al. | Nov 1986 | A |
4630604 | Montesi | Dec 1986 | A |
4641647 | Behan | Feb 1987 | A |
4660555 | Payton | Apr 1987 | A |
4671271 | Bishop et al. | Jun 1987 | A |
4676241 | Webb | Jun 1987 | A |
4699139 | Marshall et al. | Oct 1987 | A |
4706664 | Snook et al. | Nov 1987 | A |
4711636 | Bierman | Dec 1987 | A |
4713844 | Westgate | Dec 1987 | A |
D293613 | Wingler | Jan 1988 | S |
4753233 | Grimes | Jun 1988 | A |
4767411 | Edmunds | Aug 1988 | A |
4774946 | Ackerman et al. | Nov 1988 | A |
4782832 | Trimble et al. | Nov 1988 | A |
4790829 | Bowden et al. | Dec 1988 | A |
4802857 | Laughlin | Feb 1989 | A |
4803981 | Vickery | Feb 1989 | A |
4811730 | Milano | Mar 1989 | A |
4830138 | Palmaer et al. | May 1989 | A |
4838878 | Kalt et al. | Jun 1989 | A |
4899740 | Napolitano | Feb 1990 | A |
4907584 | McGinnis | Mar 1990 | A |
4915105 | Lee | Apr 1990 | A |
4919128 | Kopala et al. | Apr 1990 | A |
4919654 | Kalt | Apr 1990 | A |
4944310 | Sullivan | Jul 1990 | A |
4945907 | Tayebi | Aug 1990 | A |
4960121 | Nelson et al. | Oct 1990 | A |
4966590 | Kalt | Oct 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4971051 | Toffolon | Nov 1990 | A |
4976698 | Stokley | Dec 1990 | A |
4989599 | Carter | Feb 1991 | A |
4996983 | Amrhein | Mar 1991 | A |
5000173 | Zalkin et al. | Mar 1991 | A |
5003633 | Itoh | Apr 1991 | A |
5005571 | Dietz | Apr 1991 | A |
5020163 | Aileo et al. | Jun 1991 | A |
5022900 | Bar-Yona et al. | Jun 1991 | A |
5023955 | Murphy, II et al. | Jun 1991 | A |
5025805 | Nutter | Jun 1991 | A |
5038772 | Kolbe et al. | Aug 1991 | A |
5042478 | Kopala et al. | Aug 1991 | A |
5046491 | Derrick | Sep 1991 | A |
5074297 | Venegas | Dec 1991 | A |
5113857 | Dickerman et al. | May 1992 | A |
5117818 | Palfy | Jun 1992 | A |
5121745 | Israel | Jun 1992 | A |
5127397 | Kohnke | Jul 1992 | A |
5137017 | Salter | Aug 1992 | A |
5138722 | Urella et al. | Aug 1992 | A |
D333015 | Farmer et al. | Feb 1993 | S |
5188101 | Tumolo | Feb 1993 | A |
5207665 | Davis et al. | May 1993 | A |
5220699 | Farris | Jun 1993 | A |
5243709 | Sheehan et al. | Sep 1993 | A |
5243971 | Sullivan et al. | Sep 1993 | A |
5245995 | Sullivan et al. | Sep 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5263939 | Wortrich | Nov 1993 | A |
5265592 | Beaussant | Nov 1993 | A |
5265595 | Rudolph | Nov 1993 | A |
5267557 | Her-Mou | Dec 1993 | A |
5269296 | Landis | Dec 1993 | A |
5271391 | Graves | Dec 1993 | A |
5304146 | Johnson et al. | Apr 1994 | A |
5299599 | Farmer et al. | May 1994 | A |
5335656 | Bowe et al. | Aug 1994 | A |
5349949 | Schegerin | Sep 1994 | A |
5355878 | Griffiths et al. | Oct 1994 | A |
5355893 | Mick et al. | Oct 1994 | A |
5364367 | Banks et al. | Nov 1994 | A |
5372130 | Stem et al. | Dec 1994 | A |
5372388 | Gargiulo | Dec 1994 | A |
5372389 | Tam et al. | Dec 1994 | A |
5372390 | Conway et al. | Dec 1994 | A |
5372391 | Bast et al. | Dec 1994 | A |
5375593 | Press | Dec 1994 | A |
5385141 | Granatiero | Jan 1995 | A |
5394568 | Brostrom et al. | Mar 1995 | A |
5396885 | Nelson | Mar 1995 | A |
5398676 | Press et al. | Mar 1995 | A |
5400776 | Bartholomew | Mar 1995 | A |
5419318 | Tayebi | May 1995 | A |
5425359 | Liou | Jun 1995 | A |
5429683 | Le Mitouard | Jul 1995 | A |
5437267 | Weinstein et al. | Aug 1995 | A |
5441046 | Starr et al. | Aug 1995 | A |
5462528 | Roewer | Oct 1995 | A |
5477852 | Landis et al. | Dec 1995 | A |
5526806 | Sansoni | Jan 1996 | A |
5488948 | Dubruille et al. | Feb 1996 | A |
5509409 | Weatherholt | Apr 1996 | A |
5513634 | Jackson | May 1996 | A |
5513635 | Bedi | May 1996 | A |
5533506 | Wood | Jul 1996 | A |
5538000 | Rudolph | Jul 1996 | A |
5538001 | Bridges | Jul 1996 | A |
5560354 | Berthon-Jones et al. | Oct 1996 | A |
5570684 | Behr | Nov 1996 | A |
5592938 | Scarberry et al. | Jan 1997 | A |
5623923 | Bertheau et al. | Apr 1997 | A |
5647357 | Barnett et al. | Jul 1997 | A |
5653228 | Byrd | Aug 1997 | A |
5655527 | Scarberry et al. | Aug 1997 | A |
5662101 | Ogden et al. | Sep 1997 | A |
5682881 | Winthrop et al. | Nov 1997 | A |
5704345 | Berthon-Jones | Jan 1998 | A |
5707342 | Tanaka | Jan 1998 | A |
5724965 | Handke et al. | Mar 1998 | A |
5735272 | Dillon et al. | Apr 1998 | A |
5740799 | Nielson | Apr 1998 | A |
5752511 | Simmons et al. | May 1998 | A |
5794619 | Edeiman et al. | Aug 1998 | A |
5807341 | Heim | Sep 1998 | A |
5842469 | Rapp | Dec 1998 | A |
5906203 | Klockseth et al. | May 1999 | A |
5918598 | Belfer et al. | Jul 1999 | A |
5921239 | McCall et al. | Jul 1999 | A |
5954049 | Foley et al. | Sep 1999 | A |
5975079 | Hellings et al. | Nov 1999 | A |
6019101 | Cotner et al. | Jan 2000 | A |
6026811 | Settle | Feb 2000 | A |
6044844 | Kwok et al. | Apr 2000 | A |
6082360 | Rudolph et al. | Jul 2000 | A |
6086118 | McNaughton et al. | Jul 2000 | A |
6095996 | Steer et al. | Aug 2000 | A |
6098205 | Schwartz et al. | Aug 2000 | A |
6109263 | Feuchtgruber | Aug 2000 | A |
6112746 | Kwok | Sep 2000 | A |
6119693 | Kwok et al. | Sep 2000 | A |
6119694 | Correa et al. | Sep 2000 | A |
6123071 | Berthon-Jones et al. | Sep 2000 | A |
6123082 | Berthon-Jones | Sep 2000 | A |
6139787 | Harrison | Oct 2000 | A |
6152137 | Schwartz et al. | Nov 2000 | A |
6193914 | Harrison | Feb 2001 | B1 |
6196223 | Belfer et al. | Mar 2001 | B1 |
6211263 | Cinelli et al. | Apr 2001 | B1 |
6231548 | Bassett | May 2001 | B1 |
6241930 | Harrison | Jun 2001 | B1 |
6258066 | Urich | Jul 2001 | B1 |
6295366 | Haller et al. | Sep 2001 | B1 |
6328038 | Kessler et al. | Dec 2001 | B1 |
6341606 | Bordewick et al. | Jan 2002 | B1 |
6347631 | Hansen et al. | Feb 2002 | B1 |
6357441 | Kwok et al. | Mar 2002 | B1 |
6358279 | Tahi et al. | Mar 2002 | B1 |
6374826 | Gunaratnam et al. | Apr 2002 | B1 |
6412487 | Gunaratnam et al. | Jul 2002 | B1 |
6412488 | Barnett et al. | Jul 2002 | B1 |
6412593 | Jones | Jul 2002 | B1 |
6419660 | Russo | Jul 2002 | B1 |
6422238 | Lithgow | Jul 2002 | B1 |
6423036 | Van Huizen | Jul 2002 | B1 |
6431172 | Bordewick | Aug 2002 | B1 |
6434796 | Speirs | Aug 2002 | B1 |
6439234 | Curti et al. | Aug 2002 | B1 |
6448303 | Paul | Sep 2002 | B1 |
6467482 | Boussignac | Oct 2002 | B1 |
6467483 | Kopacko et al. | Oct 2002 | B1 |
6470887 | Martinez | Oct 2002 | B1 |
6478026 | Wood | Nov 2002 | B1 |
6482178 | Andrews et al. | Nov 2002 | B1 |
6491034 | Gunaratnam et al. | Dec 2002 | B1 |
6513526 | Kwok et al. | Feb 2003 | B2 |
6530373 | Patron et al. | Mar 2003 | B1 |
6532961 | Kwok et al. | Mar 2003 | B1 |
6536435 | Fecteau et al. | Mar 2003 | B1 |
6561188 | Ellis | May 2003 | B1 |
6561190 | Kwok et al. | May 2003 | B1 |
6561192 | Palmer | May 2003 | B2 |
6561193 | Noble | May 2003 | B1 |
6571798 | Thornton | Jun 2003 | B1 |
6579267 | Lynch et al. | Jun 2003 | B2 |
6581601 | Ziaee | Jun 2003 | B2 |
6581602 | Kwok et al. | Jun 2003 | B2 |
6584975 | Taylor | Jul 2003 | B1 |
6595214 | Hecker et al. | Jul 2003 | B1 |
6595215 | Wood | Jul 2003 | B2 |
6607516 | Cinelli et al. | Aug 2003 | B2 |
6627289 | Dilnik et al. | Sep 2003 | B1 |
6631718 | Lovell | Oct 2003 | B1 |
6634358 | Kwok et al. | Oct 2003 | B2 |
6637434 | Noble | Oct 2003 | B2 |
6644315 | Ziaee | Nov 2003 | B2 |
6655385 | Curti et al. | Dec 2003 | B1 |
6663600 | Bierman et al. | Dec 2003 | B2 |
6669712 | Cardoso | Dec 2003 | B1 |
D485905 | Moore et al. | Jan 2004 | S |
6679257 | Robertson et al. | Jan 2004 | B1 |
6679265 | Strickland et al. | Jan 2004 | B2 |
6701927 | Kwok et al. | Mar 2004 | B2 |
6710099 | Cinelli et al. | Mar 2004 | B2 |
6766800 | Chu et al. | Jul 2004 | B2 |
6766817 | da Silva | Jul 2004 | B2 |
6776162 | Wood | Aug 2004 | B2 |
6776163 | Dougill et al. | Aug 2004 | B2 |
6789543 | Cannon | Sep 2004 | B2 |
6805117 | Ho et al. | Oct 2004 | B1 |
6807967 | Wood | Oct 2004 | B2 |
6817362 | Gelinas et al. | Nov 2004 | B2 |
6820617 | Robertson et al. | Nov 2004 | B2 |
6823865 | Drew et al. | Nov 2004 | B2 |
6823869 | Raje et al. | Nov 2004 | B2 |
6834650 | Fini | Dec 2004 | B1 |
6860270 | Sniadach | Mar 2005 | B2 |
6895965 | Scarberry et al. | May 2005 | B2 |
6907882 | Ging et al. | Jun 2005 | B2 |
6918404 | Dias da Silva | Jul 2005 | B2 |
6926004 | Schumacher | Aug 2005 | B2 |
6938620 | Payne, Jr. | Sep 2005 | B2 |
6968844 | Liland | Nov 2005 | B2 |
6972003 | Bierman et al. | Dec 2005 | B2 |
6986352 | Frater et al. | Jan 2006 | B2 |
6997177 | Wood | Feb 2006 | B2 |
7011090 | Drew et al. | Mar 2006 | B2 |
7018362 | Bierman et al. | Mar 2006 | B2 |
7052127 | Harrison | May 2006 | B2 |
7066586 | da Silva | Jun 2006 | B2 |
7076282 | Munro et al. | Jul 2006 | B2 |
7080645 | Genger et al. | Jul 2006 | B2 |
7101359 | Kline et al. | Sep 2006 | B2 |
7107989 | Frater et al. | Sep 2006 | B2 |
7146976 | McKown | Dec 2006 | B2 |
7152599 | Thomas | Dec 2006 | B2 |
7152601 | Barakat et al. | Dec 2006 | B2 |
7178525 | Matula, Jr. et al. | Feb 2007 | B2 |
7191781 | Wood | Mar 2007 | B2 |
7207328 | Altemus | Apr 2007 | B1 |
7210481 | Lovell et al. | May 2007 | B1 |
7237551 | Ho et al. | Jul 2007 | B2 |
7243723 | Surjaatmadja | Jul 2007 | B2 |
D550836 | Chandran et al. | Sep 2007 | S |
D552733 | Criscuolo et al. | Oct 2007 | S |
7285255 | Kadlec et al. | Oct 2007 | B2 |
7302950 | Berthon-Jones et al. | Dec 2007 | B2 |
7318437 | Gunaratnam et al. | Jan 2008 | B2 |
7523754 | Lithgow et al. | Apr 2009 | B2 |
7658189 | Davidson | Feb 2010 | B2 |
7958893 | Lithgow et al. | Jun 2011 | B2 |
20010020474 | Hecker et al. | Sep 2001 | A1 |
20020005198 | Kwok et al. | Jan 2002 | A1 |
20020029780 | Frater et al. | Mar 2002 | A1 |
20020046755 | DeVoss | Apr 2002 | A1 |
20020053347 | Ziaee | May 2002 | A1 |
20020066452 | Kessler et al. | Jun 2002 | A1 |
20020069872 | Gradon et al. | Jun 2002 | A1 |
20020096178 | Ziaee | Jul 2002 | A1 |
20020124849 | Billette De Villemeur | Sep 2002 | A1 |
20020143296 | Russo | Oct 2002 | A1 |
20020157673 | Kessler et al. | Oct 2002 | A1 |
20020174868 | Kwok et al. | Nov 2002 | A1 |
20020185134 | Bishop | Dec 2002 | A1 |
20030000526 | Goebel | Jan 2003 | A1 |
20030019495 | Palkon et al. | Jan 2003 | A1 |
20030075180 | Raje et al. | Apr 2003 | A1 |
20030079749 | Strickland et al. | May 2003 | A1 |
20030089373 | Gradon et al. | May 2003 | A1 |
20030111080 | Olsen et al. | Jun 2003 | A1 |
20030154980 | Berthon-Jones et al. | Aug 2003 | A1 |
20030168063 | Gambone et al. | Sep 2003 | A1 |
20030196656 | Moore et al. | Oct 2003 | A1 |
20030196658 | Ging et al. | Oct 2003 | A1 |
20040025882 | Madaus et al. | Feb 2004 | A1 |
20040025885 | Payne, Jr. | Feb 2004 | A1 |
20040045551 | Eaton et al. | Mar 2004 | A1 |
20040065328 | Amarasinghe et al. | Apr 2004 | A1 |
20040106891 | Langan et al. | Jun 2004 | A1 |
20040111104 | Schein et al. | Jun 2004 | A1 |
20040112384 | Lithgow et al. | Jun 2004 | A1 |
20040118406 | Lithgow et al. | Jun 2004 | A1 |
20040127856 | Johnson | Jul 2004 | A1 |
20040211428 | Jones | Oct 2004 | A1 |
20040226564 | Persson | Nov 2004 | A1 |
20040226566 | Gunaratnam et al. | Nov 2004 | A1 |
20050011523 | Aylsworth et al. | Jan 2005 | A1 |
20050028822 | Sleeper et al. | Feb 2005 | A1 |
20050033247 | Thompson | Feb 2005 | A1 |
20050039757 | Wood | Feb 2005 | A1 |
20050051171 | Booth | Mar 2005 | A1 |
20050051176 | Riggins | Mar 2005 | A1 |
20050056286 | Huddart et al. | Mar 2005 | A1 |
20050061326 | Payne, Jr. | Mar 2005 | A1 |
20050101933 | Marrs et al. | May 2005 | A1 |
20050150495 | Rittner et al. | Jul 2005 | A1 |
20050155604 | Ging et al. | Jul 2005 | A1 |
20050211252 | Lang et al. | Sep 2005 | A1 |
20050241644 | Gunaratnam et al. | Nov 2005 | A1 |
20050284481 | Meyer | Dec 2005 | A1 |
20060060200 | Ho et al. | Mar 2006 | A1 |
20060081250 | Bordewick et al. | Apr 2006 | A1 |
20060095008 | Lampropoulos et al. | May 2006 | A1 |
20060095009 | Lampropoulos et al. | May 2006 | A1 |
20060118117 | Berthon-Jones | Jun 2006 | A1 |
20060124131 | Chandran et al. | Jun 2006 | A1 |
20060137690 | Gunaratnam et al. | Jun 2006 | A1 |
20060174887 | Chandran et al. | Aug 2006 | A1 |
20060207597 | Wright | Sep 2006 | A1 |
20060237017 | Davidson et al. | Oct 2006 | A1 |
20060283461 | Lubke et al. | Dec 2006 | A1 |
20070023044 | Kwok et al. | Feb 2007 | A1 |
20070125387 | Zollinger et al. | Jun 2007 | A1 |
20070144525 | Davidson et al. | Jun 2007 | A1 |
20070186930 | Davidson et al. | Aug 2007 | A1 |
20070272249 | Chandran et al. | Nov 2007 | A1 |
20070282272 | Bannon et al. | Dec 2007 | A1 |
20080004573 | Kaufmann et al. | Jan 2008 | A1 |
20080006277 | Worboys et al. | Jan 2008 | A1 |
20080047560 | Veliss et al. | Feb 2008 | A1 |
20080060649 | Veliss et al. | Mar 2008 | A1 |
20080065022 | Kyvik et al. | Mar 2008 | A1 |
20080110469 | Weinberg | May 2008 | A1 |
20080200880 | Kyvik et al. | Aug 2008 | A1 |
20080257354 | Davidson et al. | Oct 2008 | A1 |
20090044808 | Guney et al. | Feb 2009 | A1 |
20090178679 | Lithgow et al. | Jul 2009 | A1 |
20100000534 | Kooij et al. | Jan 2010 | A1 |
20100018534 | Veliss et al. | Jan 2010 | A1 |
20110220114 | Lithgow et al. | Sep 2011 | A1 |
20140202464 | Lithgow et al. | Jul 2014 | A1 |
Number | Date | Country |
---|---|---|
199651130 | Oct 1996 | AU |
2005100738 | Nov 2005 | AU |
185017 | May 1907 | DE |
30 11 900 | Oct 1980 | DE |
146 688 | Feb 1981 | DE |
37 19 009 | Dec 1988 | DE |
39 27 038 | Feb 1991 | DE |
29723101 UI | Jul 1998 | DE |
197 03 526 | Aug 1998 | DE |
199 44 242 | Mar 2001 | DE |
100 02 571 | Jul 2001 | DE |
102 13 905 | Oct 2002 | DE |
10 2004 055 433 | Nov 2004 | DE |
0 288 937 | Nov 1988 | EP |
0 427 474 | May 1991 | EP |
0 466 960 | Jan 1992 | EP |
303090 | Apr 1992 | EP |
0 658 356 | Jun 1995 | EP |
0 776 679 | Jun 1997 | EP |
1099452 | May 2001 | EP |
1 116 492 | Jul 2001 | EP |
1 258 266 | Nov 2002 | EP |
1 481 702 | Dec 2004 | EP |
2 720 280 | Dec 1995 | FR |
532214 | Jan 1941 | GB |
2 176 404 | Dec 1986 | GB |
2 368 533 | May 2002 | GB |
2 385 533 | Aug 2003 | GB |
H03-007173 | Jan 1991 | JP |
2000-515784 | Nov 2000 | JP |
2003-175106 | Jun 2003 | JP |
2003-535657 | Dec 2003 | JP |
WO 1982003548 | Oct 1982 | WO |
WO 1987001950 | Apr 1987 | WO |
WO 1992020392 | Nov 1992 | WO |
WO 1992020395 | Nov 1992 | WO |
WO 1996028207 | Sep 1996 | WO |
WO 1998004310 | Feb 1998 | WO |
9812965 | Apr 1998 | WO |
WO 1998023305 | Jun 1998 | WO |
WO 1999016327 | Apr 1999 | WO |
WO 1999025410 | May 1999 | WO |
WO 1999043375 | Sep 1999 | WO |
9961088 | Dec 1999 | WO |
WO 2000020072 | Apr 2000 | WO |
WO 2000038772 | Jul 2000 | WO |
WO 2000050121 | Aug 2000 | WO |
WO 2000069521 | Nov 2000 | WO |
0078384 | Dec 2000 | WO |
WO 2000072905 | Dec 2000 | WO |
WO 2000074758 | Dec 2000 | WO |
WO 2000076568 | Dec 2000 | WO |
0162326 | Aug 2001 | WO |
0197893 | Dec 2001 | WO |
WO 2001095965 | Dec 2001 | WO |
WO 2001097892 | Dec 2001 | WO |
WO 2002038221 | May 2002 | WO |
WO 2002045784 | Jun 2002 | WO |
WO 2003090827 | Nov 2003 | WO |
WO 2003105921 | Dec 2003 | WO |
WO 2004022146 | Mar 2004 | WO |
WO 2004041342 | May 2004 | WO |
WO 2004073778 | Sep 2004 | WO |
WO 2004078230 | Sep 2004 | WO |
WO 2005053781 | Jun 2005 | WO |
WO 2005063328 | Jul 2005 | WO |
WO 2005086943 | Sep 2005 | WO |
WO 2005099801 | Oct 2005 | WO |
WO 2005110220 | Nov 2005 | WO |
WO 2005118040 | Dec 2005 | WO |
PCTAU2006000031 | Jan 2006 | WO |
PCTAU2006000417 | Mar 2006 | WO |
PCTAU2006000770 | Jun 2006 | WO |
WO 2006069415 | Jul 2006 | WO |
WO 2006074513 | Jul 2006 | WO |
WO 2006074516 | Jul 2006 | WO |
WO 2006099658 | Sep 2006 | WO |
WO 2006130903 | Dec 2006 | WO |
WO 2007009182 | Jan 2007 | WO |
WO 2007041751 | Apr 2007 | WO |
WO 2007041786 | Apr 2007 | WO |
WO 2007048174 | May 2007 | WO |
WO 2007053878 | May 2007 | WO |
PCTAU2007001936 | Dec 2007 | WO |
WO 2007143772 | Dec 2007 | WO |
WO 2007145534 | Dec 2007 | WO |
WO 2008011682 | Jan 2008 | WO |
WO 2008011683 | Jan 2008 | WO |
WO 2008040050 | Apr 2008 | WO |
WO 2008070929 | Jun 2008 | WO |
WO 2009108994 | Sep 2009 | WO |
WO 2009109004 | Sep 2009 | WO |
WO 2010028425 | Mar 2010 | WO |
Entry |
---|
Decision of Rejection issued in Japanese Application No. 2010-195597 dated Apr. 28, 2014, with English translation thereof. |
Decision to Reject the Amendments issued in corresponding Japanese Appln. No. 2010-195597 dated Apr. 28, 2014, with English translation thereof. |
Summons to Attend Oral Proceedings issued in corresponding European Appln. No. 03793493.2 dated May 6, 2014. |
Office Action issued in corresponding Japanese Application No. 2010-195597 dated Jul. 27, 2015, with English translation thereof. |
Extended European Search Report dated Jun. 3, 2015 issued in European Application No. 15160073.1. |
“Ear Loop Face Mask”. |
Adam J. Singer MD et al. “The Cyanoacrylate Topical Skin Adhesives,” American Journal of Emergency Medicine, vol. 26, 2008, pp. 490-496. |
Webster's Third New International Dictionary, 1993, Dictionary definition for adjustable, bendable, and mild steel. |
ComfortLite™, Respironics, http://comfortlite.respironics.com. |
ComfortLite™ 2, Respironics, http://comfortlite2.respironics.com. |
“If You Hate CPAP! You Need CPAP Pro®,” www.cpappro.com. |
Webster's New World Dictionary, Third College Edition 1988, definition for engaged and flexible. |
European Search Report filed on Jul. 27, 2009 in EP Application No. 07784697.0. |
European Search Report issued in EP 07845378.4, dated Dec. 1, 2009. |
Examination Report filed in New Zealand Application 539836, dated Aug. 25, 2005. |
Examiner's Report No. 3 dated Nov. 18, 2009 in New Zealand Application No. 2003275762. |
Extended European Search Report dated Mar. 19, 2009 in European Application No. EP 08161249. |
Extended European Search Report dated Sep. 3, 2009 in corresponding EP Application No. 09161984.1. |
Extended European Search Report. Application No. EP 08154854, dated Nov. 27, 2008. |
Fisher and Paykel Col.—Product Family—http://www.fphcare.com/os a/products.asp/. |
Hans Rudolph, Inc.—Mask Products—http://www.rudolphkc.com/products.php?category=MASKS. |
International Preliminary Report on Patentability for PCT/AU2004/001832, dated Jul. 3, 2006. |
International Search Report for PCT/AU2005/000803, dated Jun. 30, 2005. |
International Search Report filed in PCT/AU2006/000770, dated Aug. 3, 2006. |
International Search Report for PCT/AU2007/001052, dated Oct. 9, 2007. |
International Search Report for PCT/AU2007/001051, dated Nov. 5, 2007. |
International Search Report for PCT/AU2004/001832, dated Mar. 24, 2005. |
International Search Report for PCT/AU2007/001936, dated Mar. 4, 2008. |
Joel W. Beam, “Tissue Adhesives for Simple Traumatic Lacerations,” Journal of Athletic Training, 2008, vol. 43, No. 2, pp. 222-224. |
Merriam-Webster Online Dictionary definition of moveable from the 14th century. |
Office Action dated Dec. 22, 2009 in European Appln. No. 04802133.1. |
ResMed Co.—Mask Products—http://resmed.com/portal/site/ResMedUS/index.jsp? . . . . |
Respironics Co.—Mask Family—http://masksfamily.respironics.com/. |
Snapp Nasal Interface, Tiara Medical Systems, Inc.—http://www.tiaramed.com/asp_shops/shopdisplayproducts.asp?id=109&cat=SNAPP%2A+Nasal+Interface. |
Subbu Venkatraman et al., “Review Skin Adhesives and Skin Adhesion 1. Transdermal Drug Delivery Systems,” Biomaterials, vol. 19, 1998, pp. 1119-1136. |
Supplementary European Search Report dated Sep. 8, 2009 in European Appln. No. 04802133.1. |
Supplementary European Search Report dated Dec. 18, 2009 in European Application No. 03810331.3. |
Supplementary Search Report issued in European Appln. 05746824.1, dated Dec. 17, 2009. |
Unsolicited email from Elson Silva, PhD, dated Mar. 28, 2008, “Requesting IDS of US 6,766,817 for patents on fluids moving on porosity by Unsaturated Hydraulic Flow,” (email provided in both HTML and plain text format). |
International Search Report PCT/AU2003/001163, dated Nov. 4, 2003. |
International Search Report PCT/AU2003/001471, dated Feb. 12, 2004. |
International Search Report PCT/AU2009/000240, dated May 21, 2009. |
International Search Report PCT/AU2009/000262, dated Jun. 9, 2009. |
International Search Report PCT/AU2009/001144, dated Dec. 18, 2009. |
U.S. Appl. No. 10/385,701, filed Aug. 2003, Berthon-Jones et al. |
U.S. Appl. No. 10/533,928, filed Jul. 2005, Berthon-Jones. |
U.S. Appl. No. 10/584,711, filed Dec. 2004, Davidson. |
U.S. Appl. No. 10/781,929, filed Jan. 2008, Gunaratnam et al. |
U.S. Appl. No. 10/871,929, filed Feb. 2004, Surjaatmadja. |
U.S. Appl. No. 11/080,446, filed Jul. 2005, Ging et al. |
U.S. Appl. No. 11/447,295, filed Jun. 2006, Lubke et al. |
U.S. Appl. No. 11/474,415, filed Jun. 2006, Davidson et al. |
U.S. Appl. No. 11/491,016, filed Feb. 2007, Kwok et al. |
U.S. Appl. No. 11/597,909, filed Jul. 2007, Worboys. |
U.S. Appl. No. 11/703,082, filed Feb. 2007, Davidson. |
U.S. Appl. No. 11/878,932, filed Jul. 2007, Veliss et al. |
U.S. Appl. No. 11/878,933, Jul. 2007, Veliss et al. |
U.S. Appl. No. 12/081,696, filed Apr. 2008, Davidson et al. |
U.S. Appl. No. 12/085,191, filed May 2008, Kwok et al. |
U.S. Appl. No. 12/219,852, filed Jul. 2008, Guney et al. |
U.S. Appl. No. 12/309,696, filed Jan. 2009, Kwok et al. |
U.S. Appl. No. 12/448,250, filed Jun. 2009, Veliss et al. |
U.S. Appl. No. 12/461,448, filed Aug. 2009, Berthon-Jones. |
U.S. Appl. No. 12/478,537, filed Jun. 2009, Kooij et al. |
U.S. Appl. No. 12/656,466, filed Jan. 2010, Biener et al. |
U.S. Appl. No. 12/700,878, filed Feb. 2010, Davidson et al. |
U.S. Appl. No. 60/483,622, filed Jul. 2003, Kwok et al. |
U.S. Appl. No. 60/533,214, filed Dec. 2003, Drew. |
U.S. Appl. No. 60/634,802, filed Dec. 2004, Chandran. |
U.S. Appl. No. 60/645,672, filed Jan. 2005, Chandran. |
U.S. Appl. No. 60/795,615, filed Apr. 2006, Judson et al. |
U.S. Appl. No. 60/833,841, filed Jul. 2006, Veliss. |
U.S. Appl. No. 60/835,442, filed Aug. 2006, Selvarajan et al. |
U.S. Appl. No. 60/852,649, filed Oct. 2006, Selvarajan et al. |
U.S. Appl. No. 60/874,968, filed Dec. 2006, Kwok et al. |
U.S. Appl. No. 60/907,856, filed Apr. 2007, Davidson et al. |
U.S. Appl. No. 60/924,241, filed May 2007, Kwok et al. |
U.S. Appl. No. 60/929,393, filed Jun. 2007, Kwok et al. |
U.S. Appl. No. 60/935,179, filed Jul. 2007, Guney et al. |
U.S. Appl. No. 60/935,336, filed Aug. 2007, Davidson et al. |
U.S. Appl. No. 60/996,160, filed Nov. 2007, Guney et al. |
U.S. Appl. No. 61/006,409, filed Jan. 2008, Guney et al. |
U.S. Appl. No. 61/064,818, filed Mar. 2008, Guney et al. |
U.S. Appl. No. 61/071,512, filed May 2008, Guney et al. |
EP Supplementary Search Report issued in EP Appln. 03793493 (dated Dec. 2, 2009). |
Office Action issued in European Appln. No. 03793493.2 (dated Mar. 18, 2011). |
Office Action issued in Japanese Appln. No. 2009-140433 (dated Aug. 20, 2011). |
Office Action issued in Chinese Appln. No. 201010000226.3 (dated Apr. 26, 2012). |
Office Action issued in Japanese Appln. No. 2010-1955897 (dated Jun. 12, 2012). |
Notice of Allowance issued in Japanese Appln. No. 2009-140433 (dated Sep. 4, 2012). |
Office Action issued in Chinese Appln. No. 201010000226.3 (dated Jan. 14, 2013). |
Office Action issued in Chinese Appln. No. 201010000226.3 (dated Jun. 3, 2013). |
Office Action issued in European Appln. No. 03 793 493.2 (dated Jun. 7, 2013). |
Final Office Action issued in Japanese Appln. No. 2010-195597 (dated Jun. 25, 2013). |
Number | Date | Country | |
---|---|---|---|
20170296768 A1 | Oct 2017 | US |
Number | Date | Country | |
---|---|---|---|
60483622 | Jul 2003 | US | |
60424686 | Nov 2002 | US | |
60342854 | Dec 2001 | US | |
60317486 | Sep 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10655622 | Sep 2003 | US |
Child | 12382517 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14251000 | Apr 2014 | US |
Child | 15638580 | US | |
Parent | 13067211 | May 2011 | US |
Child | 14251000 | US | |
Parent | 12382517 | Mar 2009 | US |
Child | 13067211 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10235846 | Sep 2002 | US |
Child | 10655622 | US |